Journal of Antibiotics

Papers
(The H4-Index of Journal of Antibiotics is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-10-01 to 2025-10-01.)
ArticleCitations
Substance Index for Volume 74159
Two new aromatic tenvermectins from mutant Streptomyces avermitilis HU02-0655
Therapeutic potential of isoallolithocholic acid in methicillin-resistant Staphylococcus Aureus peritoneal infection45
Evaluation of A-ring hydroxymethylene-amino- triterpenoids as inhibitors of SARS-CoV-2 spike pseudovirus and influenza H1N129
Sporogen-AO1 inhibits eukaryotic translation elongation28
Anti-MRSA activity of chlorophenyl pyrrolo benzodiazepines compound27
Determining the absolute configuration of vanitaracin A, an anti-hepatitis B virus agent26
Streptomyces maremycinicus sp. nov. and its secondary metabolite-biosynthetic gene clusters24
Inhibition of the ATP synthase increases sensitivity of Escherichia coli carrying mcr-1 to polymyxin B23
Micrococcus lacusdianchii sp. nov., an attached bacterium inhibited by metabolites from its symbiotic algae21
New antimalarial iromycin analogs produced by Streptomyces sp. RBL-029220
Trehangelin E, a bisacyl trehalose with plant growth promoting activity from a rare actinomycete Polymorphospora sp. RD06448320
Antibacterial and antibiofilm activities of ZIF-6720
Acknowledgments19
Synthesis and biological evaluation of nectriatide derivatives, potentiators of amphotericin B activity19
Tumescenamide C, a cyclic lipodepsipeptide from Streptomyces sp. KUSC_F05, exerts antimicrobial activity against the scab-forming actinomycete Streptomyces scabiei17
Butorphanol inhibits angiogenesis and migration of hepatocellular carcinoma and regulates MAPK pathway16
Microbacterium kunmingensis sp. nov., an attached bacterium of Microcystis aeruginosa16
TNF-α-induced down-regulation of type I interferon receptor contributes to acquired resistance of cervical squamous cancer to Cisplatin16
0.058422088623047